Recent News

• 09.11.2025 - First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
• 08.26.2025 - Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.19.2025 - Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
• 07.31.2025 - Teleflex Announces Quarterly Dividend
• 07.31.2025 - Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
• 07.17.2025 - Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
• 07.01.2025 - Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business
• 06.12.2025 - New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
• 06.11.2025 - Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Recent Filings

• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.31.2025 - 8-K Current report
• 07.31.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2025 - EX-99.1 EX-99.1
• 06.30.2025 - 8-K Current report